Nanologica AB
Research Nanologica AB (NICA) on Bullrun: market cap SEK 145.65M, P/E 1.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNICA
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 145.65M
- P/E1.6
- Financial periodQ1 2026
- RevenueSEK 21.46M
- Net incomeSEK 65.19M
- Free cash flow-SEK 6.25M
- Gross margin77.1%
Valuation Snapshot
latest market cap is SEK 145.65M; P/E is 1.6.
Peer valuation comparison
Latest P/E is 1.58x versus a Healthcare sector median of 24.46x (93.5% below).
Latest P/E is 1.58x versus a Sweden median of 18.57x (91.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.57 | SEK 3.55M | SEK 21.47M | SEK 22.65M |
| FY2024 | SEK 14.54M | -SEK 65.63M | -SEK 81.00M | n/a | -1.32 | SEK 48.43M | SEK 50.94M | SEK 74.11M |
| FY2023 | SEK 1.44M | -SEK 75.16M | -SEK 37.60M | n/a | -2.08 | SEK 10.05M | SEK 0 | -SEK 1.90M |
| FY2022 | SEK 1.56M | -SEK 55.23M | -SEK 46.82M | n/a | n/a | SEK 70.32M | SEK 1.33M | SEK 73.16M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | SEK 145.65M | 1.6 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Nanologica AB
Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-based purification media for preparative chromatography that is developed for the purification of peptide drugs, such as insulin and GLP-1 analogues; NLAB Idun, an ion exchange product for robust, reproducible, and efficient downstream purification of GLP-1 analogues and other peptides;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nanologica AB's market cap?
Nanologica AB's market capitalization is SEK 145.65M.
What is Nanologica AB's P/E ratio?
Nanologica AB's price-to-earnings (P/E) ratio is 1.6.
What does Nanologica AB do?
Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally.